NCT06429982View on ClinicalTrials.gov

Dexamethasone Use in Pediatric Rhabdomyolysis Patients in Addition to Standard Protocols

PHASE1RecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

October 1, 2024

Primary Completion Date

December 1, 2025

Study Completion Date

December 31, 2026

Conditions
Rhabdomyolysis
Interventions
DRUG

Dexamethasone

Steroid five day treatment

DRUG

Placebo

Placebo control group

Trial Locations (1)

20010

RECRUITING

Childrens National, Washington D.C.

Sponsors
All Listed Sponsors
lead

Children's National Research Institute

OTHER